WEI Feifei 魏菲菲

… Alternative Names

魏菲菲ウェイフェイフェイ

Less

Researcher Number	50833969
Other IDs	https://orcid.org/0000-0002-5770-3255
Affiliation (Current)	2024: 地方独立行政法人神奈川県立病院機構神奈川県立がんセンター(臨床研究所), 臨床研究所がん免疫療法研究開発学部, 研究員
Affiliation (based on the past Project Information) *help	2022: 地方独立行政法人神奈川県立病院機構神奈川県立がんセンター(臨床研究所), 臨床研究所がん免疫療法研究開発学部, 研究員
Review Section/Research Field	Principal Investigator Basic Section 55010:General surgery and pediatric surgery-related
Keywords	Principal Investigator 低侵襲 / 末梢血可溶性因子 / 機械学習 / 層別化 / がん免疫療法

Establishment of an AI-based platform for predicting response to cancer immunotherapyPrincipal Investigator
- Principal Investigator
  
  魏菲菲
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 55010:General surgery and pediatric surgery-related
- Research Institution
  Kanagawa Cancer Center Research Institute

All 2023 2022

All Journal Article Presentation

[Journal Article] Clinical roles of soluble PD-1 and PD-L1 in plasma of NSCLC patients treated with immune checkpoint inhibitors.2023
- Author(s)
  Hidetomo Himuro, Yoshiro Nakahara, Yuka Igarashi, Taku Kouro, Naoko Higashijima, Norikazu Matsuo, Shuji Murakami, Feifei Wei, Shun Horaguchi, Kayoko Tsuji, Yasunobu Mano, Haruhiro Saito, Koichi Azuma, Tetsuro Sasada
- Journal Title
  
  Cancer Immunology, Immunotherapy
  
  Volume: na Issue: 8 Pages: 2829-2840
- DOI
  10.1007/s00262-023-03464-w
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K08724
[Journal Article] 腫瘍細胞からネットワークへ－遺伝子変異とサイトカインネットワークによる腫瘍微小環境の形成と制御2022
- Author(s)
  魏菲菲、笹田哲朗
- Journal Title
  
  医学のあゆみ
  
  Volume: 281 Pages: 374-380
- Data Source
  KAKENHI-PROJECT-22K08724
[Presentation] 機械学習を用いた末梢血サイトカインに基づくがん免疫治療層別化予測ツールの開発2022
- Author(s)
  魏菲菲、東公一、中原善朗、齋藤春洋、紅露拓、氷室秀知、洞口俊、辻嘉代子、笹田哲朗
- Organizer
  第81回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-22K08724

1. 笹田哲朗 (70293967)

# of Collaborated Projects: 1 results

# of Collaborated Products: 3 results

WEI Feifei 魏菲菲

魏菲菲ウェイフェイフェイ

Research Projects

Research Products

Co-Researchers

Establishment of an AI-based platform for predicting response to cancer immunotherapyPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] Clinical roles of soluble PD-1 and PD-L1 in plasma of NSCLC patients treated with immune checkpoint inhibitors.2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] 腫瘍細胞からネットワークへ－遺伝子変異とサイトカインネットワークによる腫瘍微小環境の形成と制御2022

Author(s)

Journal Title

Data Source

[Presentation] 機械学習を用いた末梢血サイトカインに基づくがん免疫治療層別化予測ツールの開発2022

Author(s)

Organizer

Data Source

WEI Feifei 魏 菲菲

魏 菲菲 ウェイ フェイフェイ

Research Projects

Research Products

Co-Researchers

Establishment of an AI-based platform for predicting response to cancer immunotherapyPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] Clinical roles of soluble PD-1 and PD-L1 in plasma of NSCLC patients treated with immune checkpoint inhibitors.2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] 腫瘍細胞からネットワークへ－遺伝子変異とサイトカインネットワークによる腫瘍微小環境の形成と制御2022

Author(s)

Journal Title

Data Source

[Presentation] 機械学習を用いた末梢血サイトカインに基づくがん免疫治療層別化予測ツールの開発2022

Author(s)

Organizer

Data Source

WEI Feifei 魏菲菲

魏菲菲ウェイフェイフェイ